Numotech
Industry:Healthcare & Health Technologies
Export Market:United Arab Emirates, Saudi Arabia
Multiple agreements valued at a total of $80 million in 2024, in addition to anticipated future export sales of $20 million.
“It was very valuable to us to be part of the California Pavilion at Arab Health. It helped us stand out at such a large show. We had a great experience.” – Dr. Robert Felton, President
Numotech Inc. joined the California Pavilion at Arab Health in 2024 with the goal of increasing its understanding of the Middle Eastern markets, meeting new customers, and exploring the potential of establishing a presence in the Dubai Free Trade Zone. While at the show. Numotech met with important Middle Eastern healthcare stakeholders, including representatives from the Royal Family of the Emirates. As a result of attending Arab Health, Numotech was able to partner with a California medical company owned by Dr. Sarkis Mesrobian, who also helped to secure over $80 million in sales agreements and negotiated participation in the Dubai free trade zone. Now, Numotech is ramping up production in California, creating new jobs, and opening a sales office in Dubai.
Numotech’s flagship product, the Numobag®, is a cost-effective, disposable, lightweight, wound healing medical device that produces Topical Hyperbaric Oxygen Therapy (THOT®). The Numobag has been clinically validated to heal large skin lesions rapidly and has proven to arrest wound advancement to prevent lower limb amputations.
Numotech’s new disruptive technology, the Numobag® Disposable Isolation System (N-DIS) is a portable, single-use, disposable disease containment system designed for transporting infectious patients through uncontaminated areas or for transporting and protecting patients through contaminated areas. N-DIS is designed to minimize the risk of exposure of first responders, nurses, and physicians while allowing medical care to be provided to patients in transport.
Website: https://numotech.net/
Publication Date: July 10, 2024